Loading...

Ebrahimi Ramin

Title(s)Member, CTSI
SchoolCTSI
Phone310 824-7707
vCardDownload vCard
    Other Positions
    Title(s)Health Sciences Clinical Professor, Medicine


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Asatryan B, Ebrahimi R, Strebel I, van Dam PM, Kühne M, Knecht S, Spies F, Abächerli R, Badertscher P, Kozhuharov N, Zeljkovic I, Schaer B, Osswald S, Sticherling C, Reichlin T. Man vs machine: Performance of manual vs automated electrocardiogram analysis for predicting the chamber of origin of idiopathic ventricular arrhythmia. J Cardiovasc Electrophysiol. 2019 Dec 16. PMID: 31840899.
      View in: PubMed
    2. Almassi GH, Hawkins RB, Bishawi M, Shroyer AL, Hattler B, Quin JA, Collins JF, Bakaeen FG, Ebrahimi R, Grover FL, Wagner TH. New-onset postoperative atrial fibrillation impact on 5-year clinical outcomes and costs. J Thorac Cardiovasc Surg. 2019 Nov 14. PMID: 31866082.
      View in: PubMed
    3. Bailey KL, Mantha A, Sanaiha Y, Mathias L, Benharash P, Ebrahimi R. Short-Term Outcomes After Percutaneous Coronary Intervention in Patients With Autoimmune Vasculitides. J Am Coll Cardiol. 2019 Jul 09; 74(1):159-160. PMID: 31272540.
      View in: PubMed
    4. Hattler B, Carr BM, Messenger J, Spertus J, Ebrahimi R, Bishawi M, Quin JA, Almassi GH, Collins JF, Kozora E, Grover FL, Shroyer ALW. Clinical and Angiographic Predictors of Patient-Reported Angina 1 Year After Coronary Artery Bypass Graft Surgery. Circ Cardiovasc Qual Outcomes. 2019 Apr; 12(4):e005119. PMID: 31001997.
      View in: PubMed
    5. Rudasill SE, Sanaiha Y, Xing H, Mardock AL, Khoury H, Jaman R, Ebrahimi R, Benharash P. Association of Autoimmune Connective Tissue Disease and Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation. Am J Cardiol. 2019 May 15; 123(10):1675-1680. PMID: 30850212.
      View in: PubMed
    6. Han JK, Yano EM, Watson KE, Ebrahimi R. Cardiovascular Care in Women Veterans. Circulation. 2019 02 19; 139(8):1102-1109. PMID: 30779640.
      View in: PubMed
    7. Ebrahimi R, Tan W. Role of Music for Conscious Sedation During Invasive Cardiac Catheterization. Am J Cardiol. 2018 09 15; 122(6):1095-1097. PMID: 30072130.
      View in: PubMed
    8. Ebrahimi R, Gupta S, Carr BM, Bishawi M, Bakaeen FG, Almassi GH, Collins J, Grover FL, Quin JA, Wagner TH, Shroyer ALW, Hattler B. Comparison of Outcomes and Costs Associated With Aspirin?±?Clopidogrel After Coronary Artery Bypass Grafting. Am J Cardiol. 2018 03 15; 121(6):709-714. PMID: 29402422.
      View in: PubMed
    9. Juo YY, Mantha A, Ebrahimi R, Ziaeian B, Benharash P. Incidence of Myocardial Infarction After High-Risk Vascular Operations in Adults. JAMA Surg. 2017 Nov 15; 152(11):e173360. PMID: 28877308.
      View in: PubMed
    10. Mantha A, Juo YY, Morchi R, Ebrahimi R, Ziaeian B, Shemin RJ, Benharash P. Evolution of Surgical Aortic Valve Replacement in the Era of Transcatheter Valve Technology. JAMA Surg. 2017 11 01; 152(11):1080-1083. PMID: 28724144.
      View in: PubMed
    11. Ebrahimi R, Han JK, Goe SH, Treadwell M, Feliciano Z. Patient Characteristics and Clinical Outcomes with Low-Dose Dabigatran. Front Cardiovasc Med. 2017; 4:42. PMID: 28740848.
      View in: PubMed
    12. Jiang X, Peng FH, Liu QQ, Zhao QH, He J, Jiang R, Wang L, Xu XQ, Li JH, Ebrahimi R, Jing ZC. Optical coherence tomography for hypertensive pulmonary vasculature. Int J Cardiol. 2016 Nov 01; 222:494-498. PMID: 27505340.
      View in: PubMed
    13. Ebrahimi R, Uberoi A, Treadwell M, Sadrzadeh Rafie AH. Effect of Low-Frame Invasive Coronary Angiography on Radiation and Image Quality. Am J Cardiol. 2016 07 15; 118(2):195-7. PMID: 27241835.
      View in: PubMed
    14. Brunetta J, Moreno Guillén S, Antinori A, Yeni P, Wade B, Johnson M, Shalit P, Ebrahimi R, Johnson B, Walker I, De-Oertel S. Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial. Patient. 2015 Jun; 8(3):257-67. PMID: 25808940.
      View in: PubMed
    15. Moyle GJ, Orkin C, Fisher M, Dhar J, Anderson J, Wilkins E, Ewan J, Ebrahimi R, Wang H. A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals. PLoS One. 2015; 10(2):e0116297. PMID: 25658097.
      View in: PubMed
    16. Almassi GH, Wagner TH, Carr B, Hattler B, Collins JF, Quin JA, Ebrahimi R, Grover FL, Bishawi M, Shroyer AL. Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass Trial. Ann Thorac Surg. 2015 Jan; 99(1):109-14. PMID: 25442992.
      View in: PubMed
    17. Arribas JR, Pialoux G, Gathe J, Di Perri G, Reynes J, Tebas P, Nguyen T, Ebrahimi R, White K, Piontkowsky D. Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial. Lancet Infect Dis. 2014 Jul; 14(7):581-9. PMID: 24908551.
      View in: PubMed
    18. Shroyer AL, Hattler B, Wagner TH, Baltz JH, Collins JF, Carr BM, Almassi GH, Quin JA, Hawkins RB, Kozora E, Bishawi M, Ebrahimi R, Grover FL. Comparing off-pump and on-pump clinical outcomes and costs for diabetic cardiac surgery patients. Ann Thorac Surg. 2014 Jul; 98(1):38-44; discussion 44-5. PMID: 24841548.
      View in: PubMed
    19. Cohen C, Wohl D, Arribas JR, Henry K, Van Lunzen J, Bloch M, Towner W, Wilkins E, Ebrahimi R, Porter D, White K, Walker I, Chuck S, De-Oertel S, Fralich T. Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults. AIDS. 2014 Apr 24; 28(7):989-97. PMID: 24508782.
      View in: PubMed
    20. Gupta SK, Anderson AM, Ebrahimi R, Fralich T, Graham H, Scharen-Guivel V, Flaherty JF, Fortin C, Kalayjian RC, Rachlis A, Wyatt CM. Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients. PLoS One. 2014; 9(3):e92717. PMID: 24651857.
      View in: PubMed
    21. Robertson JO, Ebrahimi R, Lansky AJ, Mehran R, Stone GW, Lincoff AM. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy). JACC Cardiovasc Interv. 2014 Apr; 7(4):372-9. PMID: 24630881.
      View in: PubMed
    22. Palella FJ, Fisher M, Tebas P, Gazzard B, Ruane P, Van Lunzen J, Shamblaw D, Flamm J, Ebrahimi R, Porter D, White K, Hindman J, Elbert E, De-Oertel S, Fralich T. Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants. AIDS. 2014 Jan 28; 28(3):335-44. PMID: 24670520.
      View in: PubMed
    23. Cao H, Yu F, Zhao Y, Scianmarello N, Lee J, Dai W, Jen N, Beebe T, Li R, Ebrahimi R, Chang DS, Mody FV, Pacella J, Tai YC, Hsiai T. Stretchable electrochemical impedance sensors for intravascular detection of lipid-rich lesions in New Zealand White rabbits. Biosens Bioelectron. 2014 Apr 15; 54:610-6. PMID: 24333932.
      View in: PubMed
    24. Ebrahimi R, Bakaeen FG, Uberoi A, Ardehali A, Baltz JH, Hattler B, Almassi GH, Wagner TH, Collins JF, Grover FL, Shroyer AL. Effect of clopidogrel use post coronary artery bypass surgery on graft patency. Ann Thorac Surg. 2014 Jan; 97(1):15-21. PMID: 24206971.
      View in: PubMed
    25. Ahmadi N, Hajsadeghi F, Conneely M, Mingos M, Arora R, Budoff M, Ebrahimi R. Accurate detection of metabolically active "brown" and "white" adipose tissues with computed tomography. Acad Radiol. 2013 Nov; 20(11):1443-7. PMID: 24119358.
      View in: PubMed
    26. Almassi GH, Shroyer AL, Collins JF, Hattler B, Bishawi M, Baltz JH, Ebrahimi R, Grover FL. Chronic obstructive pulmonary disease impact upon outcomes: the veterans affairs randomized on/off bypass trial. Ann Thorac Surg. 2013 Oct; 96(4):1302-1309. PMID: 23915589.
      View in: PubMed
    27. Bhulani N, Khawaja A, Jafferani A, Baqir M, Ebrahimi R, Sajjad Z. Coronary calcium scoring: are the results comparable to computed tomography coronary angiography for screening coronary artery disease in a South Asian population? BMC Res Notes. 2013 Jul 19; 6:279. PMID: 23866861.
      View in: PubMed
    28. Ahmadi N, Nabavi V, Hajsadeghi F, Zeb I, Flores F, Ebrahimi R, Budoff M. Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis. Int J Cardiol. 2013 Oct 03; 168(3):2310-4. PMID: 23453866.
      View in: PubMed
    29. Ahmadi N, Eshaghian S, Huizenga R, Sosnin K, Ebrahimi R, Siegel R. Effects of intense exercise and moderate caloric restriction on cardiovascular risk factors and inflammation. Am J Med. 2011 Oct; 124(10):978-82. PMID: 21798505.
      View in: PubMed
    30. Ahmadi N, Hajsadeghi F, Mirshkarlo HB, Budoff M, Yehuda R, Ebrahimi R. Post-traumatic stress disorder, coronary atherosclerosis, and mortality. Am J Cardiol. 2011 Jul 01; 108(1):29-33. PMID: 21530936.
      View in: PubMed
    31. Ahmadi N, Hajsadeghi F, Blumenthal RS, Budoff MJ, Stone GW, Ebrahimi R. Mortality in individuals without known coronary artery disease but with discordance between the Framingham risk score and coronary artery calcium. Am J Cardiol. 2011 Mar 15; 107(6):799-804. PMID: 21247539.
      View in: PubMed
    32. Ahmadi N, Nabavi V, Hajsadeghi F, Flores F, French WJ, Mao SS, Shavelle D, Ebrahimi R, Budoff M. Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography. Am J Cardiol. 2011 Jan; 107(1):10-6. PMID: 21146679.
      View in: PubMed
    33. Ahmadi N, Mao SS, Hajsadeghi F, Hacioglu Y, Flores F, Gao Y, Ebrahimi R, Budoff M. Relation of subclinical left and right ventricular dysfunctions measured by computed tomography angiography with the severity of coronary artery disease. Coron Artery Dis. 2011; 22(6):380-7. PMID: 21666441.
      View in: PubMed
    34. Nabavi V, Ahmadi N, Bhatia HS, Flores F, Ebrahimi R, Karlsberg RP, Budoff MJ. Increased carotid wall thickness measured by computed tomography is associated with the presence and severity of coronary artery calcium. Atherosclerosis. 2011 Mar; 215(1):103-9. PMID: 21196006.
      View in: PubMed
    35. Frank Peacock W, Varon J, Ebrahimi R, Dunbar L, Pollack CV. Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis. Blood Press Suppl. 2011 Apr; 1:20-5. PMID: 21091269.
      View in: PubMed
    36. Ahmadi N, Nabavi V, Yang E, Hajsadeghi F, Lakis M, Flores F, Zeb I, Bevinal M, Ebrahimi R, Budoff M. Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium. Acad Radiol. 2010 Dec; 17(12):1518-24. PMID: 20947390.
      View in: PubMed
    37. Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Dellow E, Herbrecht R, Donnelly JP. Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease. Mycoses. 2011 Sep; 54(5):e449-55. PMID: 21039936.
      View in: PubMed
    38. Kumar D, Dangas G, Mehran R, Kirtane A, Bertrand M, Ebrahimi R, Guagliumi G, Brar S, Fahy M, Heller E, Moses J, Stone G. Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators). Am J Cardiol. 2010 Oct 01; 106(7):941-5. PMID: 20854954.
      View in: PubMed
    39. Ahmadi N, Nabavi V, Hajsadeghi F, Flores F, Azmoon S, Ismaeel H, Shavelle D, Mao SS, Ebrahimi R, Budoff MJ. Impaired aortic distensibility measured by computed tomography is associated with the severity of coronary artery disease. Int J Cardiovasc Imaging. 2011 Mar; 27(3):459-69. PMID: 20711815.
      View in: PubMed
    40. Azmoon S, Pucillo AL, Aronow WS, Ebrahimi R, Vozzolo J, Rajdev A, Kalapatapu K, Ro JH, Hjemdahl-Monsen C. Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device. J Invasive Cardiol. 2010 Apr; 22(4):175-8. PMID: 20351388.
      View in: PubMed
    41. Peacock F, Varon J, Ebrahimi R, Dunbar L, Pollack CV. Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis. Congest Heart Fail. 2010 Mar-Apr; 16(2):55-9. PMID: 20412469.
      View in: PubMed
    42. Ahmadi N, Tsimikas S, Hajsadeghi F, Saeed A, Nabavi V, Bevinal MA, Kadakia J, Flores F, Ebrahimi R, Budoff MJ. Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium. Am J Cardiol. 2010 Feb 15; 105(4):459-66. PMID: 20152239.
      View in: PubMed
    43. Hodder SL, Mounzer K, Dejesus E, Ebrahimi R, Grimm K, Esker S, Ecker J, Farajallah A, Flaherty JF. Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF. AIDS Patient Care STDS. 2010 Feb; 24(2):87-96. PMID: 20156091.
      View in: PubMed
    44. Sanborn TA, Ebrahimi R, Manoukian SV, McLaurin BT, Cox DA, Feit F, Hamon M, Mehran R, Stone GW. Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Circ Cardiovasc Interv. 2010 Feb 01; 3(1):57-62. PMID: 20118151.
      View in: PubMed
    45. Ahmadi N, Shavelle D, Nabavi V, Hajsadeghi F, Moshrefi S, Flores F, Azmoon S, Mao SS, Ebrahimi R, Budoff M. Coronary distensibility index measured by computed tomography is associated with the severity of coronary artery disease. J Cardiovasc Comput Tomogr. 2010 Mar-Apr; 4(2):119-26. PMID: 20430343.
      View in: PubMed
    46. Fisher M, Moyle GJ, Shahmanesh M, Orkin C, Kingston M, Wilkins E, Ewan J, Liu H, Ebrahimi R, Reilly G. A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals. J Acquir Immune Defic Syndr. 2009 Aug 15; 51(5):562-8. PMID: 19561519.
      View in: PubMed
    47. Mehran R, Nikolsky E, Lansky AJ, Kirtane AJ, Kim YH, Feit F, Manoukian S, Moses JW, Ebrahimi R, Ohman EM, White HD, Pocock SJ, Dangas GD, Stone GW. Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy. JACC Cardiovasc Interv. 2009 Aug; 2(8):748-57. PMID: 19695543.
      View in: PubMed
    48. Maier M, Geiger EV, Henrich D, Ebrahimi R, Wutzler S, Lehnert M, Marzi I. Apoptosis differs in dendritic cell subsets early after severe trauma. Hum Immunol. 2009 Oct; 70(10):803-8. PMID: 19589364.
      View in: PubMed
    49. Dejesus E, Young B, Morales-Ramirez JO, Sloan L, Ward DJ, Flaherty JF, Ebrahimi R, Maa JF, Reilly K, Ecker J, McColl D, Seekins D, Farajallah A. Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients. J Acquir Immune Defic Syndr. 2009 Jun 01; 51(2):163-74. PMID: 19357529.
      View in: PubMed
    50. Ebrahimi R, Dyke C, Mehran R, Manoukian SV, Feit F, Cox DA, Gersh BJ, Ohman EM, White HD, Moses JW, Ware JH, Lincoff AM, Stone GW. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol. 2009 May 26; 53(21):1965-72. PMID: 19460609.
      View in: PubMed
    51. Movahed MR, Kern K, Thai H, Ebrahimi R, Friedman M, Slepian M. Coronary artery bifurcation lesions: a review and update on classification and interventional techniques. Cardiovasc Revasc Med. 2008 Oct-Dec; 9(4):263-8. PMID: 18928952.
      View in: PubMed
    52. Elion R, Cohen C, Ward D, Ruane P, Ortiz R, Reddy YS, Ebrahimi R, McColl D, Kearney B, Fisher A, Flaherty J. Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily. HIV Clin Trials. 2008 Jul-Aug; 9(4):213-24. PMID: 18753116.
      View in: PubMed
    53. Pollack CV, Varon J, Garrison NA, Ebrahimi R, Dunbar L, Peacock WF. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. 2009 Mar; 53(3):329-38. PMID: 18534716.
      View in: PubMed
    54. Ebrahimi R, Saleh J, Toggart E, Shah AP, Azmoon S, Babaei H, Lee J, Smith R, Movahed MR, Rubin SA. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis. J Invasive Cardiol. 2008 Jun; 20(6):292-5. PMID: 18523323.
      View in: PubMed
    55. Feit F, Manoukian SV, Ebrahimi R, Pollack CV, Ohman EM, Attubato MJ, Mehran R, Stone GW. Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2008 Apr 29; 51(17):1645-52. PMID: 18436116.
      View in: PubMed
    56. DeJesus E, Ruane P, McDonald C, Garcia F, Sharma S, Corales R, Ravishankar J, Khanlou H, Shamblaw D, Ecker J, Ebrahimi R, Flaherty J. Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine. HIV Clin Trials. 2008 Mar-Apr; 9(2):103-14. PMID: 18474495.
      View in: PubMed
    57. Movahed MR, Ebrahimi R. The prevalence of valvular abnormalities in patients who were referred for echocardiographic examination with a primary diagnosis of "heart murmur". Echocardiography. 2007 May; 24(5):447-51. PMID: 17456061.
      View in: PubMed
    58. Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A, Aoun M, Horst HA, Thiebaut A, Ruhnke M, Reichert D, Vianelli N, Krause SW, Olavarria E, Herbrecht R. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007 May 15; 44(10):1289-97. PMID: 17443465.
      View in: PubMed
    59. Movahed MR, Saito Y, Ahmadi-Kashani M, Ebrahimi R. Mitral annulus calcification is associated with valvular and cardiac structural abnormalities. Cardiovasc Ultrasound. 2007 Mar 14; 5:14. PMID: 17359540.
      View in: PubMed
    60. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, King SB, Ohman EM, Stone GW. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol. 2007 Mar 27; 49(12):1362-8. PMID: 17394970.
      View in: PubMed
    61. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006 Nov 23; 355(21):2203-16. PMID: 17124018.
      View in: PubMed
    62. Kearney BP, Mathias A, Mittan A, Sayre J, Ebrahimi R, Cheng AK. Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir. J Acquir Immune Defic Syndr. 2006 Nov 01; 43(3):278-83. PMID: 17079992.
      View in: PubMed
    63. Exaire JE, Butman SM, Ebrahimi R, Kleiman NS, Harrington RA, Schweiger MJ, Bittl JA, Wolski K, Topol EJ, Lincoff AM. Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. Am Heart J. 2006 Jul; 152(1):157-63. PMID: 16824849.
      View in: PubMed
    64. Ramanathan S, Cheng A, Mittan A, Ebrahimi R, Kearney BP. Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects. J Clin Pharmacol. 2006 May; 46(5):559-66. PMID: 16638739.
      View in: PubMed
    65. Ebrahimi R, Lincoff AM, Bittl JA, Chew D, Wolski K, Wadhan N, Toggart EJ, Topol EJ. Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis. J Cardiovasc Pharmacol Ther. 2005 Dec; 10(4):209-16. PMID: 16382257.
      View in: PubMed
    66. Kearney BP, Ramanathan S, Cheng AK, Ebrahimi R, Shah J. Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration. J Clin Pharmacol. 2005 Aug; 45(8):935-40. PMID: 16027404.
      View in: PubMed
    67. Ebrahimi R, Saleh JR, Toggart EJ, Hayatdavoudi B, Wolf CJ, Wadhani NN, Shah AP. Lipid-lowering therapy in patients with peripheral arterial disease. J Cardiovasc Pharmacol Ther. 2004 Dec; 9(4):271-7. PMID: 15678246.
      View in: PubMed
    68. Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA. 2004 Aug 11; 292(6):696-703. PMID: 15304466.
      View in: PubMed
    69. Srivatsa UN, Ebrahimi R, El-Bialy A, Wachsner RY. Electrical storm: case series and review of management. J Cardiovasc Pharmacol Ther. 2003 Sep; 8(3):237-46. PMID: 14506549.
      View in: PubMed
    70. Jafari M, Ebrahimi R, Ahmadi-Kashani M, Balian H, Bashir M. Efficacy of alternate-day dosing versus daily dosing of atorvastatin. J Cardiovasc Pharmacol Ther. 2003 Jun; 8(2):123-6. PMID: 12808485.
      View in: PubMed
    71. Chang KY, Ebrahimi R, Bersohn MM. Ventricular fibrillation resulting from acute right ventricular infarction from isolated occlusion of a right ventricular branch artery. J Cardiovasc Pharmacol Ther. 2003 Mar; 8(1):5-8. PMID: 12652324.
      View in: PubMed
    72. Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Kereiakes DJ, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003 Feb 19; 289(7):853-63. PMID: 12588269.
      View in: PubMed